Undetectable brain natriuretic peptide as a marker of ultrasound-detected hypovolemia in patients with cancer on active treatment.

Le ATT, Qarajeh R, Wilder B, Sharma A, Golemi L, Okwuosa T

Open source

DOI
10.3389/fcvm.2026.1606572
Published
2026
Container
Frontiers in cardiovascular medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcvm.2026.1606572,
  title = {Undetectable brain natriuretic peptide as a marker of ultrasound-detected hypovolemia in patients with cancer on active treatment.},
  author = {Le ATT and Qarajeh R and Wilder B and Sharma A and Golemi L and Okwuosa T},
  year = {2026},
  journal = {Frontiers in cardiovascular medicine},
  doi = {10.3389/fcvm.2026.1606572},
  url = {https://doi.org/10.3389/fcvm.2026.1606572}
}

RIS

TY  - JOUR
TI  - Undetectable brain natriuretic peptide as a marker of ultrasound-detected hypovolemia in patients with cancer on active treatment.
AU  - Le ATT
AU  - Qarajeh R
AU  - Wilder B
AU  - Sharma A
AU  - Golemi L
AU  - Okwuosa T
PY  - 2026
JO  - Frontiers in cardiovascular medicine
DO  - 10.3389/fcvm.2026.1606572
UR  - https://doi.org/10.3389/fcvm.2026.1606572
ER  - 

APA

ATT, L., R, Q., B, W., A, S., L, G., & T, O. (2026). Undetectable brain natriuretic peptide as a marker of ultrasound-detected hypovolemia in patients with cancer on active treatment.. Frontiers in cardiovascular medicine. https://doi.org/10.3389/fcvm.2026.1606572

Source records